Vitamin D Supplementation Protects Telomeres in VITAL

This transcript has been edited for clarity.  This is Dr JoAnn Manson, professor of medicine at Harvard Medical School and Brigham and Women’s Hospital. I’d like to talk with you about a recent report in the American Journal of Clinical Nutrition that suggests vitamin D supplementation has a promising role in protecting telomeres and slowing … Read more

A Rising Threat to Cancer Care

As Hurricane Helene approached western North Carolina, Martin Palmeri, MD, MBA, didn’t anticipate the storm would disrupt practice operations for more than a day or so. But the massive rainfall and flooding damage last September proved to be far more challenging. Despite best efforts by the 13-physician practice, basic treatments for most patients were interrupted … Read more

Cancer Deaths Fall in Europe, but Not Across All Types

Cancer statistics in Europe are encouraging: Between 1989 and 2025, nearly 7 million deaths were averted in the European Union (EU), including over 373,000 from breast cancer. This finding emerged from a study recently published in the Annals of Oncology by a team of researchers led by Carlo La Vecchia from the University of Milan … Read more

Low-Dose Apixaban Best for Long-Term Use in Cancer

CHICAGO — Extended therapy with reduced-dose apixaban is just as effective as the high dose in preventing recurrent venous thromboembolism (VTE) in patients with active cancer who completed at least 6 months of anticoagulant treatment after a clot, and results in a lower rate of clinically relevant bleeding, the API-CAT trial shows. “Our results indicate … Read more

Untangling Race-based Disparities in Endometrial Cancer

Tiffany White Tiffany White was 27 years old when she was diagnosed with endometrial cancer. White, a Chicago resident who works as a mental health counselor and an accounting director for a national nonprofit organization, presented to her gynecologist with tiredness, pain, and bleeding between periods. An ultrasound revealed the presence of polyps. After a … Read more

Acute EOL Care Increased in Patients With Advanced Cancer

TOPLINE: Among Medicare beneficiaries with advanced cancer, 45% had more than one acute care visit, in-hospital mortality, late receipt of systemic therapy, or hospice entry in the last 30 days of life. METHODOLOGY: Historical evidence has shown that patients with advanced cancer often receive potentially aggressive care at the end of life, including late initiation … Read more